SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Technology Stocks : TAVA Technologies (TAVA-NASDAQ) -- Ignore unavailable to you. Want to Upgrade?


To: Manzanillo who wrote (27939)2/11/1999 10:38:00 PM
From: Bill Wexler  Read Replies (1) | Respond to of 31646
 
<<You have been saying that for over two years now.>>

And I've been correct for two years. The fact the stock price doesn't reflect it yet is irrelevant. Scams can hang on for a very long time...but ultimately, the stock price fully reflects the lack of earnings power. Take a look at one of my favorite examples: COPY.

<<Didn't you use to have the screen name Harddata over on Motley Fool on AOL?>>

No. I only post here and on Yahoo occasionaly. In both cases I use my name.

<<I made a bundle with ZONA>>

I doubt it.

<<and am sure will do the same with TAVA>>

Why? Were you intelligent enough to short TAVA when it was 14?

<<If you can't do anything to a stock like ZONA with almost no float, your impact on TAVA would be similar to a mosquito biting an elephant.>>

I don't see your point. I'm simply stating an opinion. I'm not "doing" anything to either stock. My short positions in TAVA never exceeded 25,000 shares, which is insignificant compared to the float.

<<Why didn't you wait then? Everyone knows the approximate time for the FDA final approval. Why short the stock in August? Don't you know what good timing means?>>

Timing in stock-picking is a fantasy concocted by the same people who bought you the "technical analysis" fraud. You can't "time" a stock, and you can't determine future prices from past price history. That's why you don't see any multi-billionaire technical analysts running around. I shorted Zonagen at 35...I also shorted Zonagen at 15, because Zonagen is not worth 15...and it certainly is not worth 35. By the time FDA rejection rolls around it will be too late to initiate a position. What it does until then is irrelevant. I will only cover when the stock price accurately reflects Zonagen's real underlying value.